T cells in tumors and blood predict outcome in follicular lymphoma treated with rituximab

Björn Engelbrekt Wahlin, Christer Sundström, Harald Holte, Hans Hagberg, Martin Erlanson, Herman Nilsson-Ehle, Ola Lindén, Marie Nordström, Bjørn Ostenstad, Christian H Geisler, Peter de Nully Brown, Tuula Lehtinen, Martin Maisenhölder, Anne M Tierens, Birgitta Sander, Birger Christensson, Eva Kimby

    43 Citationer (Scopus)

    Abstract

    T cells influence outcome in follicular lymphoma, but their contributions seem to be modified by therapy. Their impact in patients receiving rituximab without chemotherapy is unknown.
    OriginalsprogEngelsk
    TidsskriftClinical Cancer Research
    Vol/bind17
    Udgave nummer12
    Sider (fra-til)4136-44
    Antal sider9
    ISSN1078-0432
    DOI
    StatusUdgivet - 2011

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'T cells in tumors and blood predict outcome in follicular lymphoma treated with rituximab'. Sammen danner de et unikt fingeraftryk.

    Citationsformater